ILBS hosts Wilson India 2026 to boost advocacy and access to Trientene
New Delhi: The Institute of Liver and Biliary Sciences (ILBS), New Delhi, today hosted a dedicated Wilson Disease Patient Advocacy Program as part of “Wilson India 2026,” a single‑topic, two‑day international conference endorsed by the Asia Pacific Association for the Study of the Liver (APASL). The advocacy program brought together patients, families, clinicians, and international experts with the shared goal of strengthening the collective voice of the Wilson disease community in India.
Wilson disease is a hereditary copper overload disorder that can lead to liver cirrhosis and neurological manifestations, affecting approximately 1 in 30,000 children and young adults. As a liver‑centric university and referral center for complex liver diseases, ILBS manages nearly 25–30 new Wilson disease cases each year.
The conference, hosted by the Department of........
